Stockholders put Noodles, Clovis shares on sale block

BOULDER – Two very different publicly traded local companies have seen success served up in rising share prices in recent years.

Restaurant chain Noodles & Co. Inc. and biopharmaceutical developer Clovis Oncology Inc. announced stock sales in early December, creating future cash wealth estimated in the hundreds of millions of dollars, mostly for shareholders.

Companies and stockholders hold such sales when they think they can get the best prices, said Robert Pyle, a certified financial planner who heads Diversified Asset Management Inc., a wealth-management firm in Boulder. The stock market has gained about 30 percent this year, an indication that the market…